Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5347351

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of P13Kgamma (unknown origin)
15
Total Activities
15
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Publication

Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents.
Occhiuzzi MA, Lico G, Ioele G, De Luca M, Garofalo A, Grande F.
Eur J Med Chem (2023) 246 : 114971 -114971
PubMed 36462440 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 15 7.89 9.54

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL3984425 EGANELISIB 2.0 1 9.54
CHEMBL3218576 COPANLISIB 4.0 1 9.15
CHEMBL3544966 GSK-1059615 1.0 1 8.30
CHEMBL4126156 1 8.10
CHEMBL3545366 VOXTALISIB 2.0 1 8.05
CHEMBL3813842 PAXALISIB 2.0 1 8.00
CHEMBL5278435 1 7.89
CHEMBL1922094 APITOLISIB 2.0 1 7.85
CHEMBL4297181 SAMOTOLISIB 2.0 1 7.62
CHEMBL3393066 VS-5584 1.0 1 7.60
CHEMBL2064571 1 7.57
CHEMBL4297584 TENALISIB 2.0 1 7.48
CHEMBL586702 ZSTK-474 2.0 1 7.31
CHEMBL3039502 DUVELISIB 4.0 1 7.30
CHEMBL2017974 BUPARLISIB 3.0 1 6.58

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL3984425 EGANELISIB IC50 = 0.29 nM 9.54
CHEMBL3218576 COPANLISIB IC50 = 0.7 nM 9.15
CHEMBL3544966 GSK-1059615 IC50 = 5.0 nM 8.30
CHEMBL4126156 IC50 = 7.9 nM 8.10
CHEMBL3545366 VOXTALISIB IC50 = 9.0 nM 8.05
CHEMBL3813842 PAXALISIB IC50 = 10.0 nM 8.00
CHEMBL5278435 IC50 = 13.0 nM 7.89
CHEMBL1922094 APITOLISIB IC50 = 14.0 nM 7.85
CHEMBL4297181 SAMOTOLISIB IC50 = 23.8 nM 7.62
CHEMBL3393066 VS-5584 IC50 = 25.0 nM 7.60
CHEMBL2064571 IC50 = 27.0 nM 7.57
CHEMBL4297584 TENALISIB IC50 = 33.2 nM 7.48
CHEMBL586702 ZSTK-474 IC50 = 49.0 nM 7.31
CHEMBL3039502 DUVELISIB IC50 = 50.0 nM 7.30
CHEMBL2017974 BUPARLISIB IC50 = 262.0 nM 6.58